nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Placental Biology and Genetic Risk for Schizophrenia
June 18, 2018   

In a recent study, the relationship between placenta biology and genetic risk for schizophrenia in the presence of early-life complications (ELCs) was examined...
 Continue reading (Members only)
Risk of Antidepressant-Induced Weight Gain
June 15, 2018   

A population-based cohort study examined the relationship between antidepressant treatment and weight gain over 10 years...
 Continue reading (Members only)
Recommendations for Suicide Prevention Released
June 8, 2018   

A panel of experts, as part of the National Action Alliance for Suicide Prevention, has recently published guidelines aimed at improving suicide prevention across a range of health care organizations, including primary care, emergency room, and inpatient and outpatient mental health care settings...
 Continue reading
Proposed ICD-11 PTSD Criteria May Lead to Missed Diagnoses
June 5, 2018   

A recent study examined whether changes to post-traumatic stress disorder (PTSD) diagnostic criteria in the upcoming International Classification of Diseases (ICD)-11 may affect the prevalence and identification of PTSD cases...
 Continue reading (Members only)
FDA Approves First Non-Opioid to Treat Opioid Withdrawal Symptoms
May 21, 2018   

The US FDA has approved the first non-opioid treatment for the relief of opioid withdrawal symptoms. The medication, lofexidine hydrochloride (trade name Lucemyra), is an oral, selective alpha-2 adrenergic receptor agonist...
 Continue reading
A Novel Preventive Treatment for Migraine
May 18, 2018   

The first treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide (CGRP), a molecule that is involved in migraine attacks has been FDA-approved...
 Continue reading (Members only)
Mama Bare: Depression During Pregnancy and the Postpartum Period
May 16, 2018   

Pregnancy and the birth of a child are often viewed as joyous, miraculous events. However, a significant portion of women suffer with depression during pregnancy and in the postpartum period...
 Continue reading
2018 APA Highlight: Self-Harm and Suicide Death Among Adolescents and Young Adults
May 7, 2018   

During the 2018 American Psychiatric Association (APA) Annual Meeting, experts discussed the current state treatment-resistant depression (TRD) in adolescents and suicidality from different perspectives...
 Continue reading
2018 APA Highlight: Immunotherapies in Schizophrenia and Bipolar Disorder
May 5, 2018   

During the 2018 American Psychiatric Association (APA) Annual Meeting, Dr. Mark Weiser discussed the latest therapies being investigated to treat inflammation in schizophrenia and bipolar disorder...
 Continue reading
FDA Advisory Committee Unanimously Supports Approval of Cannabidiol Formulation for Severe Epilepsy
May 1, 2018   

A US FDA Advisory Committee has unanimously voted to support the approval of a plant-based cannabidiol formulation for the adjunct treatment of seizures associated with two severe forms of epilepsy...
 Continue reading
12345678910...
Top of Page